Characteristics of all CLL patients using IGHV3-21 gene
. | Total . | France . | Greece . | Italy . | Spain . |
|---|---|---|---|---|---|
| No. IGHV3-21 cases | 16 | 4 | 7 | 4 | 1 |
| Frequency, % | 2.9 | 2.7 | 3.7 | 4.1 | 0.9 |
| Mean age, y | 70.7 | 63.5 | 67 | 79.5 | 90* |
| Sex, no. F/no. M | 8/8 | 2/2 | 4/3 | 1/3 | 1/0 |
| No. mutated/no. unmutated | 7/9 | 2/2 | 2/5 | 2/2 | 1/0 |
| IGHV homology, no. | |||||
| At least 98% | 9 | 2 | 5 | 2 | 0 |
| 98%-96% | 3 | 0 | 1 | 1 | 1 |
| Less than 96% | 4 | 2 | 1 | 1 | 0 |
| LC, no. κ/no. λ | 7/9 | 2/2 | 4/3 | 1/3 | 0/1 |
| IGV LC homology, no. | |||||
| At least 98% | 14 | 3 | 7 | 3 | 1 |
| 98%-96% | 2 | 1 | 0 | 1 | 0 |
| Less than 96% | 0 | 0 | 0 | 0 | 0 |
| CD38, % | |||||
| Neg | 5 | 0 | 4 | 1 | 0 |
| Pos | 10 | 3 | 3 | 3 | 1 |
| Stage at diagnosis | |||||
| A | 8 | 1 | 5 | 2 | 0 |
| B | 5 | 3 | 1 | 1 | 0 |
| C | 3 | 0 | 1 | 1 | 1 |
| Clinical course | |||||
| Stable | 5 | 0 | 4 | 1 | 0 |
| Progressive | 11 | 4 | 3 | 3 | 1 |
| Need for treatment | 11 | 4 | 3 | 3 | 1 |
| CLL-related death | 4 | 2 | 0 | 1 | 1 |
. | Total . | France . | Greece . | Italy . | Spain . |
|---|---|---|---|---|---|
| No. IGHV3-21 cases | 16 | 4 | 7 | 4 | 1 |
| Frequency, % | 2.9 | 2.7 | 3.7 | 4.1 | 0.9 |
| Mean age, y | 70.7 | 63.5 | 67 | 79.5 | 90* |
| Sex, no. F/no. M | 8/8 | 2/2 | 4/3 | 1/3 | 1/0 |
| No. mutated/no. unmutated | 7/9 | 2/2 | 2/5 | 2/2 | 1/0 |
| IGHV homology, no. | |||||
| At least 98% | 9 | 2 | 5 | 2 | 0 |
| 98%-96% | 3 | 0 | 1 | 1 | 1 |
| Less than 96% | 4 | 2 | 1 | 1 | 0 |
| LC, no. κ/no. λ | 7/9 | 2/2 | 4/3 | 1/3 | 0/1 |
| IGV LC homology, no. | |||||
| At least 98% | 14 | 3 | 7 | 3 | 1 |
| 98%-96% | 2 | 1 | 0 | 1 | 0 |
| Less than 96% | 0 | 0 | 0 | 0 | 0 |
| CD38, % | |||||
| Neg | 5 | 0 | 4 | 1 | 0 |
| Pos | 10 | 3 | 3 | 3 | 1 |
| Stage at diagnosis | |||||
| A | 8 | 1 | 5 | 2 | 0 |
| B | 5 | 3 | 1 | 1 | 0 |
| C | 3 | 0 | 1 | 1 | 1 |
| Clinical course | |||||
| Stable | 5 | 0 | 4 | 1 | 0 |
| Progressive | 11 | 4 | 3 | 3 | 1 |
| Need for treatment | 11 | 4 | 3 | 3 | 1 |
| CLL-related death | 4 | 2 | 0 | 1 | 1 |
Actual age of the single patient of the Spanish series.